Local relapse and peritoneal carcinomatosis (PC) for pT4 colon cancer is estimated in 15,6% and 36,7% for 12 months and 36 months from surgical resection respectively, achieving a 5 years overall survival of 6%. | HIPECT4 Multicentre randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy HIPEC with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma